New year, new way to partner with WARF

100+ UW-Madison technologies now available for express licensing

CONTACT:
Jeanan Yasiri Moe
Director of Strategic Communications and Public Affairs
[email protected] | (608) 960-9892

MADISON, Wis. - To simplify industry collaboration, the Wisconsin Alumni Research Foundation has launched express licensing for more than 100 technologies developed at the University of Wisconsin-Madison. Available now, this streamlined approach offers industry partners a faster, easier way to license high-impact materials and chemicals, research tools, clean technologies and more.

As WARF begins a second century of advancing research and discovery, this initiative reflects a continued commitment to removing barriers and accelerating collaboration. The express licensing platform serves as a one-stop shop for accessing a curated portfolio of ready-to-license technologies, enabling companies to move quickly from interest to agreement.

"Express licensing is about meeting industry where they are, providing speed, simplicity and transparency," says Jeanine Burmania, WARF senior director of IP and licensing. "We're excited to offer this new pathway to partnership and to share the incredible breadth of innovation coming from UW-Madison."

Technologies available through express licensing span multiple disciplines and are ideal for startups, established companies and research institutions seeking to enhance their pipelines with proven academic discoveries.

To explore available technologies and learn more, visit expresslicensing.warf.org/products.

About WARF

Incorporated in 1925, the Wisconsin Alumni Research Foundation (WARF) patents and licenses discoveries from UW-Madison research, manages an investment portfolio generated from licensing and investment proceeds, and provides annual grants to the University of Wisconsin-Madison and the Morgridge Institute for Research to support further scientific investigation and research. By driving collaborations among researchers, investors, industry and entrepreneurs, WARF commercializes innovations from campus through various initiatives. WARF Accelerator improves the commercialization potential of university intellectual property through industry engagement and investment in proof-of-concept milestones to validate market potential, demonstrate commercial value and de-risk technology. WARF Therapeutics partners with UW-Madison and Morgridge Institute researchers employing an industry-focused approach to improve the value propositions of drug candidates. WARF Ventures is an early-stage venture fund that invests in startups based on UW/WARF technologies. Learn more at warf.org.

###